Kimball Electronics, Inc.

Kimball Electronics, Inc.

Overview

Kimball Electronics is a contract manufacturer that combines Electronics Manufacturing Services (EMS) with Contract Development and Manufacturing Organization (CDMO) capabilities. Under the Kimball Solutions brand (introduced in 2026), the company offers integrated manufacturing for both electronics and non-electronics products, including medical disposables, drug delivery systems, precision molded plastics, and related CDMO services. The company is pursuing a name change to Kimball Solutions, Inc., subject to Share Owners’ approval at the 2026 Annual Meeting.

Business model and offerings

Kimball operates as a single strategic supplier offering services across the product lifecycle, integrating EMS and CDMO capabilities to serve multiple end markets.

Core services and capabilities:

• Production and testing of printed circuit board assemblies (PCBAs)
• High-level and final assembly for automotive, medical, and industrial products
• Design services and Design for Excellence (DfX)
• Supply chain services and procurement
• Rapid prototyping and new product introduction (NPI)
• Product design, process validation, and qualification
• Industrialization and automation of manufacturing processes
• Reliability testing under extreme conditions
• Aftermarket services
• Production and assembly of medical devices and medical disposables, including packaging
• Drug delivery devices and solutions (with and without electronics)
• Clean room assembly (Class 7 and 8), cold chain management, and product sterilization management
• Design engineering and production of precision molded plastics
• Complete product lifecycle management

The company emphasizes a global footprint, standardized processes, global sourcing, and a CRM-based model to provide customers access to services across regions and lifecycle stages.

Key customers and revenue mix

• The three largest customers accounted for approximately 40% of net sales in fiscal year 2026.
• Nexteer Automotive: ~18% of net sales (2026)
• Philips: ~11% of net sales (2026)
• ZF: ~11% of net sales (2026)

End markets and product mix

Revenue by end market (2024–2026):

• Automotive: 46%
• Medical: 29%
• Industrial: 25%

Employees and governance

• Employees: approximately 5,600 worldwide
  • ~1,000 in the United States
  • ~4,600 in foreign countries
• Governance and leadership diversity:
  • Three independent directors are female
  • 50% of the Board’s leadership is female
  • ~43% of the executive leadership team is female
• Executive officers (as of August 19, 2026):
  • Richard D. Phillips — Chief Executive Officer
  • Adam M. Baumann — Chief Administrative Officer
  • Jana T. Croom — Chief Financial Officer
  • Jessica L. DeLorenzo — Chief Human Resources Officer
  • Douglas A. Hass — Chief Legal & Administrative Officer, Secretary
  • Steven T. Korn — Chief Operating Officer
  • Andrew D. Regrut — Vice President, Investor Relations, Strategic Development, and Treasurer
  • Kathy R. Thomson — Chief Commercial Officer

Global footprint and facilities

As of August 19, 2026, the company operates 11 facilities involved in contract manufacturing and related services:

• United States: 3 facilities in Indiana (two fully operational; a third leased facility to expand medical CDMO footprint; when fully operational it will replace the Indianapolis facility)
• Mexico: 2 facilities
• Poland: 1 facility
• Romania: 1 facility
• The Netherlands: 1 facility (additional leased facility for support services)
• India: 1 facility
• China: 1 facility
• Thailand: 1 facility

Other facility and property notes:

• The Netherlands and India facilities were acquired on July 1, 2026.
• A Tampa facility was sold in 2026.
• Headquarters: 42,000-square-foot building in Jasper, Indiana.
• The company owns approximately 83 acres of land, including land on which facilities reside.

Acquisitions and branding

• Completed acquisition of Helvoet Polymer Technologies B.V. on July 1, 2026. Helvoet expands capabilities in precision molded plastics, complex tooling, and medical device component manufacturing, supporting integrated EMS and CDMO solutions for medical and pharmaceutical markets.
• Introduced the Kimball Solutions brand in 2026 to represent the expanded non-electronics manufacturing portfolio and is seeking a corporate name change pending shareholder approval.

Intellectual property and innovation

• Primary IP consists of proprietary manufacturing technology, processes, know-how, and confidential information used to deliver manufacturing services.
• The company relies on trade secret protections, trademarks (Kimball Electronics and Kimball Solutions), and contractual arrangements to protect and manage IP, along with use of customer-owned or customer-licensed IP where applicable.

Sustainability, governance, and risk posture

• The company reports on environmental, social, and governance (ESG) initiatives through its Guiding Principles Report and aligns reporting with frameworks such as GRI, UN SDGs/UNGC, SASB, and TCFD.
• Participates in CDP climate change and water security questionnaires.
• Maintains responsible sourcing and conflict minerals (3TG) policies, is a member of the Responsible Minerals Initiative (RMI), and conducts supplier due diligence.
• Focuses on data security and cybersecurity controls and has governance measures related to the use of artificial intelligence and applicable regulatory considerations.